Idiopathic Pulmonary Fibrosis (IPF) Learning Zone
Key Learning
Living with IPF: Patient perspectives
Introduction
Interstitial lung diseases (ILDs) include over 200 fibroinflammatory diseases that affect the alveolar interstitium of the lung1,2.
The most common of these is idiopathic pulmonary fibrosis (IPF) which accounts for between 17–37% of ILDs1.
This content has been developed independently of the sponsors, Boehringer Ingelheim, who have had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.